Narrative Update • Jun 22
Have your own idea? Try our Stock Screener
German (DAX) Pharma Industry Analysis
UpdatedJun 24, 2026
DataAggregated Company Financials
Companies9
- 7D3.9%
- 3M15.5%
- 1Y29.3%
- YTD7.6%
Over the last 7 days, the Pharma industry has risen 3.9%, driven by gains from Merck KGaA of 5.0%. This takes the industry's 12 month performance to a gain of 29%. As for the next few years, earnings are expected to grow by 23% per annum.
Industry Valuation and Performance
Has the German Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 25 Jun 2026 | €98.9b | €67.4b | €482.6m | 23.2x | 204.9x | 1.5x |
| Sat, 23 May 2026 | €96.9b | €67.4b | €511.4m | 22.1x | 189.5x | 1.4x |
| Mon, 20 Apr 2026 | €95.0b | €67.9b | -€888,580,858.50 | 19.3x | -107x | 1.4x |
| Wed, 18 Mar 2026 | €90.6b | €67.9b | -€900,303,492.13 | 18.8x | -100.6x | 1.3x |
| Fri, 13 Feb 2026 | €102.2b | €68.3b | €2.9b | 17.8x | 35.6x | 1.5x |
| Sun, 11 Jan 2026 | €96.8b | €68.3b | €2.9b | 18.3x | 33.8x | 1.4x |
| Tue, 09 Dec 2025 | €89.2b | €68.5b | €2.9b | 17.6x | 31x | 1.3x |
| Thu, 06 Nov 2025 | €77.0b | €68.8b | -€439,184,343.01 | 18.2x | -175.4x | 1.1x |
| Sat, 04 Oct 2025 | €83.9b | €68.8b | -€439,008,342.28 | 19.2x | -191.1x | 1.2x |
| Mon, 01 Sep 2025 | €77.7b | €68.9b | -€406,133,953.93 | 17.2x | -191.4x | 1.1x |
| Wed, 30 Jul 2025 | €79.6b | €69.4b | -€283,071,598.00 | 17.9x | -281.3x | 1.1x |
| Fri, 27 Jun 2025 | €76.8b | €69.4b | -€293,702,195.00 | 17.6x | -261.6x | 1.1x |
| Sun, 25 May 2025 | €76.2b | €69.4b | -€206,564,479.00 | 18.1x | -368.9x | 1.1x |
| Tue, 22 Apr 2025 | €73.9b | €69.3b | €463.1m | 17.8x | 159.6x | 1.1x |
| Thu, 20 Mar 2025 | €85.1b | €69.2b | €436.0m | 21x | 195.1x | 1.2x |
| Sat, 15 Feb 2025 | €82.8b | €69.2b | €2.0b | 21.9x | 40.9x | 1.2x |
| Mon, 13 Jan 2025 | €84.4b | €69.2b | €2.0b | 23x | 42x | 1.2x |
| Wed, 11 Dec 2024 | €85.4b | €69.2b | €2.0b | 22.3x | 42.1x | 1.2x |
| Fri, 08 Nov 2024 | €92.0b | €69.4b | €1.6b | 20.2x | 58.9x | 1.3x |
| Sun, 06 Oct 2024 | €99.0b | €69.3b | €1.5b | 21.6x | 67.3x | 1.4x |
| Tue, 03 Sep 2024 | €106.0b | €69.3b | €1.5b | 25.6x | 72x | 1.5x |
| Thu, 01 Aug 2024 | €101.6b | €69.2b | -€303,627,757.00 | 30.1x | -334.5x | 1.5x |
| Sat, 29 Jun 2024 | €95.7b | €69.2b | -€327,989,929.00 | 29.5x | -291.9x | 1.4x |
| Mon, 27 May 2024 | €102.7b | €69.2b | -€310,351,180.00 | 21.5x | -330.9x | 1.5x |
| Wed, 24 Apr 2024 | €96.0b | €70.0b | -€34,208,180.00 | 20.6x | -2806.6x | 1.4x |
| Fri, 22 Mar 2024 | €98.7b | €70.0b | €6.5m | 18.8x | 15195.1x | 1.4x |
| Sun, 18 Feb 2024 | €98.4b | €70.6b | -€650,504,143.00 | 19.4x | -151.3x | 1.4x |
| Tue, 16 Jan 2024 | €98.4b | €70.6b | -€650,504,143.00 | 20.3x | -151.3x | 1.4x |
| Thu, 14 Dec 2023 | €92.1b | €70.6b | -€650,606,256.00 | 17.8x | -141.5x | 1.3x |
| Sat, 11 Nov 2023 | €106.9b | €70.6b | -€625,796,256.00 | 16.7x | -170.9x | 1.5x |
| Mon, 09 Oct 2023 | €114.0b | €72.1b | €4.7b | 18.7x | 24.4x | 1.6x |
| Wed, 06 Sep 2023 | €126.6b | €72.1b | €4.7b | 21.7x | 27.2x | 1.8x |
| Fri, 04 Aug 2023 | €125.0b | €74.1b | €6.5b | 17x | 19.4x | 1.7x |
| Sun, 02 Jul 2023 | €118.8b | €74.1b | €6.5b | 18.5x | 18.4x | 1.6x |
Price to Earnings Ratio
18.4x
Current Industry PE
- Investors are optimistic on the German Pharmaceuticals industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 205x which is higher than its 3-year average PE of 131x.
- The industry is trading close to its 3-year average PS ratio of 1.3x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have declined 58% per year over the last three years,
- Revenues have also declined 3.1% per year.
- This means overall sales from these companies are declining and profits are subsequently falling as well.
Industry Trends
Which industries have driven the changes within the German Healthcare industry?
| DE Market | -0.95% | |
| Healthcare | 1.33% | |
| Pharma | 3.88% | |
| Pharma | 3.88% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| MRK Merck KGaA | €140.10 | 5.0% +€2.9b | 27.0% | PE24.1x | |
| BAYN Bayer | €39.61 | 5.0% +€1.8b | 50.0% | PS0.9x | |
| 93M1 MPH Health Care | €28.10 | 1.8% +€2.1m | 44.1% | PS2.4x |